Table 1.
Results of discovery, replication and validation for the HIGH and LOW/MID phenotypes.
| Gene | SNP | chr | pos | EA | EAF | Discovery (n = 9,675) | Replication | Validation | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HIGH | LOW/MID | European ancestry only | All ancestries | UK Biobank (n = 356,141) | |||||||||||||||||
| beta | dir | P | beta | dir | P | beta | P | dir | N | beta | P | dir | N | beta | P | ||||||
| IPP | rs61784824 | 1 | 46211347 | A | 0.71 | −0.083 | −−−−−− | 5.59E-07 | −0.049 | −−−−−− | 1.94E-03 | −0.089 | 0.011 | ?− | 2,122 | −0.018 | 0.244 | ?−+− | 9,749 | −0.032 | 4.05E-08 * |
| CTH | rs61776709 | 1 | 70994590 | A | 0.87 | −0.083 | −−−−−− | 1.70E-04 | −0.110 | −−−−−− | 1.51E-07 | 0.087 | 0.052 | ?++ | 2,158 | 0.012 | 0.520 | ?+++− | 9,794 | −0.007 | 4.00E-01 |
| SPTBN1 | rs6740893 | 2 | 54834380 | A | 0.23 | 0.062 | ++++++ | 3.39E-04 | 0.091 | ++++++ | 3.22E-08 * | 0.002 | 0.954 | −+ | 3,319 | −0.019 | 0.221 | −+− | 10,955 | 0.029 | 3.09E-06 * |
| ILDR1 | rs2332035 | 3 | 121715432 | T | 0.29 | 0.100 | ++++++ | 7.83E-10 * | 0.070 | ++++++ | 4.77E-06 | 0.015 | 0.600 | +++ | 3,283 | −0.008 | 0.594 | ++++− | 10,91 | 0.032 | 1.47E-07 * |
| TRIL | rs12112406 | 7 | 28937083 | A | 0.26 | 0.091 | ++++++ | 3.88E-07 | 0.059 | ++++++ | 4.99E-04 | 0.061 | 0.032 | +++ | 3,283 | −0.011 | 0.512 | +++− | 10,91 | 0.024 | 7.21E-05 * |
| RP11-32K4.1 | rs9298078 | 8 | 64906619 | T | 0.05 | 0.144 | ++++++ | 2.99E-05 | 0.181 | +−++++ | 3.36E-08 * | −0.011 | 0.867 | +−+ | 3,319 | −0.044 | 0.092 | +−++− | 10,955 | −0.002 | 8.61E-01 |
| DOCK9 | rs1289319 | 13 | 99457063 | T | 0.60 | −0.075 | −−−−−− | 4.84E-07 | −0.048 | −+−+− | 7.68E-04 | −0.001 | 0.974 | +−+ | 3,283 | −0.008 | 0.567 | +−++− | 10,91 | 0.001 | 8.59E-01 |
| ISG20 | rs56203268 | 15 | 89265679 | T | 0.83 | 0.086 | ++++++ | 2.51E-04 | 0.114 | ++++++ | 2.57E-07 | −0.090 | 0.034 | ?− | 2,158 | 0.005 | 0.808 | ?−+ | 9,794 | 0.037 | 1.91E-07 * |
| SPIRE2 | rs6500458 | 16 | 89907205 | A | 0.42 | −0.085 | −+−-−− | 3.12E-07 | −0.036 | −+−+− | 2.21E-02 | −0.067 | 0.011 | − | 3,283 | −0.046 | 0.002 * | −−−−− | 10,91 | NA | NA |
| FXYD5 | rs10403118 | 19 | 35677210 | A | 0.79 | −0.046 | −−−−+− | 1.83E-02 | −0.092 | −−−−−− | 4.82E-07 | −0.066 | 0.040 | − | 3,319 | −0.052 | 0.007 | −+− | 10,955 | 0.000 | 9.54E-01 |
HIGH: high frequency phenotype; LOW/MID: low and mid frequency phenotype; chr: chromosome; pos: position; EA: Effect allele; EAF: Effect allele frequency; dir: direction (for discovery cohorts: RS-II, RS-III, AGES, CHS, FHS, HABC; for replication cohorts: Antwerp, G-EAR, TwinsUK, JHS, HCHS/SOL). SNPs included are suggestively (P <1*10−6, listed in bold) or significantly (P < 5*10−8, indicated by an asterisk) associated in at least 1 phenotype. In replication and validation (UKB: UK Biobank): SNPs with nominally significant P-values (< 0.05) are listed in bold, SNPs significant after correcting for multiple testing (P = 0.005; 0.05/10 loci) are also indicated by an asterisk.